We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Efficacy of a commercial vaccine against different strains of rabbit haemorrhagic disease virus.
- Authors
Read, AJ; Kirkland, PD
- Abstract
Background This study investigated the ability of a commercial rabbit haemorrhagic disease virus ( RHDV) vaccine (Cylap®) to protect rabbits from disease caused by two different strains of the virus (v351 and K5) that are used or proposed to be used for wild rabbit control in Australia. These strains of the RHDV1 genotype belong to the 'classical RHDV' and 'antigenic variant RHDVa' subtypes, respectively. Methods Vaccinated rabbits were exposed to very high doses of the virus either by direct oral dosing or by exposure to infected rabbit livers. Results & Conclusion All vaccinated rabbits were protected against rabbit haemorrhagic disease, indicating that the Cylap® vaccine is effective against both strains of the virus under experimental conditions.
- Subjects
RABBIT calicivirus disease; RABBIT calicivirus; VACCINE effectiveness; GENOTYPES; REVERSE transcriptase polymerase chain reaction; VACCINATION
- Publication
Australian Veterinary Journal, 2017, Vol 95, Issue 7, p223
- ISSN
0005-0423
- Publication type
Article
- DOI
10.1111/avj.12600